Skip to main content
#BestACR20Tweets
RT @KDAO2011 : #ACR20 Abstr#0431 Hydroxychloroquine Use Was Not Associated with QTc Length in a Large C

Dr. John Cush RheumNow

5 years 9 months ago
#BestACR20Tweets RT @KDAO2011 : #ACR20 Abstr#0431 Hydroxychloroquine Use Was Not Associated with QTc Length in a Large Cohort of SLE and RA Patients @rheumnow https://t.co/7yn0fK1tfn
What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease and guide clinicians in assessing and treating patients. 
It is not hyperbole to acknowledge that the COVID-19 pandemic has changed the world, inflicting pain and suffering to many, and inconvenience to all. As everyone struggles to make it through these difficult times, it might be worth pointing out some small silver linings that have emerged despite this pernicious dark cloud.
#BestACR20Tweets

RT @uptoTate : Claims-based "big data" reveals PsA pts had "arthritis" coding prior to formal dx and c

Dr. John Cush RheumNow

5 years 9 months ago
#BestACR20Tweets RT @uptoTate : Claims-based "big data" reveals PsA pts had "arthritis" coding prior to formal dx and coding for enthesitis, axial dz, and arthritis increased prior to PsA dx. Coding diff between treating specialties also noted. #ACR20 https://t.co/naeRPFZdap https://t.co/E4XvlZSsX6
Ready for telemedicine/telerheumatology? Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.
Congratulations on choosing the greatest profession, one equally dedicated to both science and patient care. You are now part of a guild that will support you and anticipate your success. Rheumatology needs you to be a big thinking, futuristic problem-solving practitioner who will lead and learn, research and teach. Here are my words of wisdom for aspiring MSK phenoms.
#BestACR20Tweets

RT @uptoTate :Dactylitis is a clinical indicator for an aggressive phenotype of PsA categorized w/ sig

Dr. John Cush RheumNow

5 years 9 months ago
#BestACR20Tweets RT @uptoTate :Dactylitis is a clinical indicator for an aggressive phenotype of PsA categorized w/ significantly greater TJC, SJC, CRP, US synovitis/erosions in very early DMARD naïve pts. #ABS0312 #ACR20 https://t.co/d2ZjXRgvkE https://t.co/60n5pNfx9O https://t.co/EvsR0aJtXJ
#BestACR20Tweets

RT @RichardPAConway : Dr Fernandez-Diaz on abatacept in RA-ILD in 263 patients. Abatacept appears safe

Dr. John Cush RheumNow

5 years 9 months ago
#BestACR20Tweets RT @RichardPAConway : Dr Fernandez-Diaz on abatacept in RA-ILD in 263 patients. Abatacept appears safe and effective. Equivalent to RTX. Good option as s/c admin @rheumnow #ACR20 Abstr#0233 #ACRbest https://t.co/yqV6BoKy4s https://t.co/7jUASw5D2f
Make sure you check out the RheumNow podcast on Soundcloud or Apple/Android devices. New episodes every week!

https://

Dr. John Cush RheumNow

5 years 9 months ago
Make sure you check out the RheumNow podcast on Soundcloud or Apple/Android devices. New episodes every week! https://t.co/wjBWCrKL34 https://t.co/3z2aWfB95V
#BestACR20Tweets

RT @RichardPAConway : Really important study by @SattuiSEMD on high prevalence of frailty and its impa

Dr. John Cush RheumNow

5 years 9 months ago
#BestACR20Tweets RT @RichardPAConway : Really important study by @SattuiSEMD on high prevalence of frailty and its impact on QOL in PMR #ACR20 @rheumnow Abstr#422 https://t.co/QzDYGsqDeJ
×